{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:35:33Z","timestamp":1762004133264},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.ymgme.2008.09.001","type":"journal-article","created":{"date-parts":[[2008,10,19]],"date-time":"2008-10-19T08:19:09Z","timestamp":1224404349000},"page":"233-235","source":"Crossref","is-referenced-by-count":27,"title":["Improvement with ongoing Enzyme Replacement Therapy in advanced late-onset Pompe disease: A case study"],"prefix":"10.1016","volume":"95","author":[{"given":"Laura E.","family":"Case","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight D.","family":"Koeberl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeksha","family":"Bali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"DeArmey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Mackey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2008.09.001_bib1","series-title":"The Metabolic and Molecular Bases of Metabolic Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid \u03b1-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2001"},{"issue":"5 Suppl","key":"10.1016\/j.ymgme.2008.09.001_bib2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.ymgme.2008.09.001_bib3","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ymgme.2008.09.001_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00005792-199505000-00002","article-title":"Clinical variability in adult-onset acid maltase deficiency report of affected sibs and review of the literature","volume":"74","author":"Felice","year":"1995","journal-title":"Medicine (Baltimore)"},{"issue":"Pt. 3","key":"10.1016\/j.ymgme.2008.09.001_bib5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/brain\/awh384","article-title":"Clinical manifestation and natural course of late-onset Pompe\u2019s disease in 54 Dutch patients","volume":"128","author":"Hagemans","year":"2005","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.ymgme.2008.09.001_bib6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1212\/WNL.55.8.1122","article-title":"Juvenile and adult-onset acid maltase deficiency in France: genotype\u2013phenotype correlation","volume":"55","author":"Laforet","year":"2000","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ymgme.2008.09.001_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0022-510X(85)90050-4","article-title":"Adult-onset acid maltase deficiency. Distribution and progression of clinical and pathological abnormality in a family","volume":"68","author":"Swash","year":"1985","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.ymgme.2008.09.001_bib8","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2008.09.001_bib9","unstructured":"FDA Approves First Treatment for Pompe Disease."},{"issue":"2","key":"10.1016\/j.ymgme.2008.09.001_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00125817-200103000-00008","article-title":"Recombinant human acid \u03b1-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2008.09.001_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nmd.2004.10.009","article-title":"Safety and efficacy of recombinant acid \u03b1-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trial","volume":"15","author":"Klinge","year":"2005","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.ymgme.2008.09.001_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-2005-837543","article-title":"Enzyme replacement therapy in classical infantile pompe disease: results of a ten-month follow-up study","volume":"36","author":"Klinge","year":"2005","journal-title":"Neuropediatrics"},{"issue":"5","key":"10.1016\/j.ymgme.2008.09.001_bib13","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human \u03b1-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2003","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.ymgme.2008.09.001_bib14","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1010383421286","article-title":"Enzyme therapy for pompe disease with recombinant human \u03b1-glucosidase from rabbit milk","volume":"24","author":"Van den Hout","year":"2001","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2008.09.001_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpeds.2006.02.035","article-title":"Chinese hamster ovary cell-derived recombinant human acid \u03b1-glucosidase in infantile-onset Pompe disease","volume":"149","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.ymgme.2008.09.001_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/abio.2000.4838","article-title":"Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease","volume":"287","author":"An","year":"2000","journal-title":"Anal. Biochem."},{"issue":"2","key":"10.1016\/j.ymgme.2008.09.001_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0003-2697(03)00056-3","article-title":"Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry","volume":"316","author":"Young","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ymgme.2008.09.001_bib18","unstructured":"Myozyme [package insert], in. Cambridge, MA: Genzyme Corporation; 2007."},{"key":"10.1016\/j.ymgme.2008.09.001_bib19","series-title":"Gross Motor Function Measure (GMFM-66 & GMFM-88) User\u2019s Manual","author":"Russell","year":"2002"},{"key":"10.1016\/j.ymgme.2008.09.001_bib20","unstructured":"The FIM(TM). The Center for Outcome Measurement in Brain Injury."},{"issue":"5","key":"10.1016\/j.ymgme.2008.09.001_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2008.09.001_bib22","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/01.gim.0000217789.14470.c5","article-title":"Physical therapy management of Pompe disease","volume":"8","author":"Case","year":"2006","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2008.09.001_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2005.03.010","article-title":"Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease","volume":"85","author":"An","year":"2005","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2008.09.001_bib24","unstructured":"Protocol AGLU02804: A Single Center, Open-Label, Bridging Study of the Safety, Pharmacokinetics and Efficacy of Recombinant Human Acid \u03b1-Glucosidase (rhGAA) Treatment in Patients with Late-Onset Pompe Disease (Glycogen Storage Disease Type II)."},{"issue":"6","key":"10.1016\/j.ymgme.2008.09.001_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nmd.2008.04.009","article-title":"Eight years experience with enzyme replacement therapy in two children and one adult with Pompe disease","volume":"18","author":"van Capelle","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2008.09.001_bib26","unstructured":"A.C.P. van der Ploeg, D. Corzo, D. Escolar, J. Florence, P. Laforet, Results from a randomized, double-blind multicenter, multinational, placebo-controlled study of the safety and efficacy of Myozyme, recombinant human acid \u03b1-glucosidase (rhGAA), for the treatment of Pompe disease in juveniles and adults [abstract], in: 60th Annual Meeting of the American Academy of Neurology, Chicago, Illinois; 2008."},{"key":"10.1016\/j.ymgme.2008.09.001_bib27","unstructured":"S. Ravaglia, C. Danesino, M. Rossi, A. Pichiecchio, S. Moglia, Enzyme replacement therapy (ERT) in adult-onset type II glycogenosis (GSDII) [abstract], in: 59th Annual Meeting of the American Academy of Neurology: April 28 - May 5, 2007 2007; Boston; 2007."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2008.09.001_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.ymgme.2008.09.001_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymthe.2004.09.017","article-title":"Replacing acid \u03b1-glucosidase in Pompe disease: recombinant and transgenic enzymes are equipotent, but neither completely clears glycogen from type II muscle fibers","volume":"11","author":"Raben","year":"2005","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ymgme.2008.09.001_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-007-0519-9","article-title":"Glycogen storage disease types I and II: treatment updates","volume":"30","author":"Koeberl","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgme.2008.09.001_bib31","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.20807","article-title":"Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease","volume":"59","author":"Fukuda","year":"2006","journal-title":"Ann. Neurol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208002291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719208002291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T00:50:24Z","timestamp":1545699024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719208002291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S1096719208002291"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2008.09.001","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}